APS

2025 APS Annual Convention

Newly Engineered Mouse Lines Reveal Rules for Psychedelic Neuroplasticity in Brain Regions Lacking 5-HT2a Receptors

Sunday, May 25, 2025 · Washington, DC

Oral · Biological/Neuroscience

Psychedelic therapy is thought to work by boosting neuroplasticity onto prefrontal neurons expressing serotonin 2A receptors (5-HT2AR). We engineered new conditional knockout mouse lines to reveal psychedelic neuroplasticity of regions lacking 5-HT2AR. Physiology from 321 neurons (84 mice) causally revealed a presynaptic, not postsynaptic, basis of psychedelic neuroplasticity.

Chairs & Discussants

  • Omar AhmedSpeaker
    University of Michigan